Nepafenac dosing frequency for ocular pain and inflammation associated with cataract surgery.

Gow, James A; Song, Clara K; McNamara, Tim R

Gow, James A; Song, Clara K; McNamara, Tim R.

J Ocul Pharmacol Ther ; 25(4): 385-6; author reply 386, 2009 Aug.

Article in En | MEDLINE | ID: mdl-19552601

Subject(s)

Anti-Inflammatory Agents, Non-Steroidal/administration & dosage; Benzeneacetamides/administration & dosage; Phenylacetates/administration & dosage; Anti-Inflammatory Agents, Non-Steroidal/therapeutic use; Benzeneacetamides/therapeutic use; Cataract Extraction/adverse effects; Clinical Trials as Topic/methods; Drug Administration Schedule; Drug Approval/legislation & jurisprudence; Humans; Inflammation/drug therapy; Inflammation/etiology; Pain, Postoperative/drug therapy; Pain, Postoperative/etiology; Phenylacetates/therapeutic use; United States; United States Food and Drug Administration

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylacetates / Anti-Inflammatory Agents, Non-Steroidal / Benzeneacetamides Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: J Ocul Pharmacol Ther Journal subject: FARMACOLOGIA / OFTALMOLOGIA / TERAPEUTICA Year: 2009 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google